Approval of the Company financial statements for the fiscal year ended December 31, 2020
Approval of the consolidated financial statements for the fiscal year ended December 31, 2020
Appropriation of 2020 earnings; setting of the dividend
Authorization granted to the Board of Directors for a period of 18 months to allow the Company to trade in its own shares
Renewal of the term of office of Mr Xavier Huillard as Director
Appointment of Mr Pierre Breber as Company Director
Appointment of Mr Aiman Ezzat as Company Director
Appointment of Mr Bertrand Dumazy as Company Director
Statutory Auditors’ Special Report on agreements covered by the articles L. 225-38 et seq. of the French Commercial Code
Approval of the elements of remuneration paid during or awarded in respect of the fiscal year ended December 31, 2020 to Mr Benoît Potier
Approval of information relating to the remuneration of corporate officers stated in article L. 22-10-9 I of the French Commercial Code
Approval of the remuneration policy applicable to Executive Officers
Approval of the remuneration policy applicable to Directors
EXTRAORDINARY GENERAL MEETING
Authorization granted to the Board of Directors for a period of 24 months to reduce the share capital by cancellation of treasury shares
Delegation of authority granted to the Board of Directors for a period of 26 months in order to increase the share capital via the issuance of ordinary shares or marketable securities conferring entitlement, immediately and/or in the future, to the Company’s share capital, with retention of shareholder preferential share subscription rights for a maximum par value amount of 470 million euros
Authorization granted to the Board of Directors for a period of 26 months to increase the issuance amount of equity securities or marketable securities in the event of over-subscription
Delegation of authority granted to the Board of Directors for a period of 26 months to perform share capital increases, with cancellation of preferential subscription rights, reserved for members of a company or Group Savings Plan
Delegation of authority granted to the Board of Directors for a period of 18 months to perform share capital increases, with cancellation of preferential subscription rights, reserved for a category of beneficiaries